3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
32
Breast Neoplasms
25
Fallopian Tube Neoplasms
21
Multiple Myeloma
18
Carcinoma, Ovarian Epithelial
14
Lymphoma
8
Triple Negative Breast Neoplasms
4
Recurrence
3
Neoplasms, Plasma Cell
3
Hodgkin Disease
3
Prostatic Neoplasms
2
Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia
2
Hematologic Neoplasms
2
Burkitt Lymphoma
2
Subcutaneous panniculitis-like T-cell lymphoma
1
Solid Tumors
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Patient Participation
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neurofibrosarcoma
1
Interventions
mogamulizumab
3
Cyclophosphamide
3
Lenalidomide
2
Alemtuzumab
2
ruxolitinib
1
peginterferon alfa-2b
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
denileukin diftitox
1
belinostat
1
Zidovudine
1
Vincristine
1
Raltegravir Potassium
1
Prednisone
1
Oxaliplatin
1
Introns
1
Interleukin-15
1
Gemcitabine
1
Etoposide
1
Doxorubicin
1
Dexamethasone
1
Daclizumab
1
Cytarabine
1
Cisplatin
1
Calcium Dobesilate
1
Bortezomib
1
B3(Fv)-PE38KDEL recombinant immunotoxin
1
10-propargyl-10-deazaaminopterin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia-Lymphoma, Adult T-Cell
×
liposomal doxorubicin
×
Clear all
No trials found.